Davitt Bradley V, Dobson Velma, Quinn Graham E, Hardy Robert J, Tung Betty, Good William V
Department of Ophthalmology, Cardinal Glennon Children's Medical Center, Saint Louis University School of Medicine, St. Louis, Missouri 63104, USA.
Ophthalmology. 2009 Feb;116(2):332-9. doi: 10.1016/j.ophtha.2008.09.035. Epub 2008 Dec 16.
To examine the prevalence of astigmatism (> or =1.00 diopter [D]) and high astigmatism (> or =2.00 D) at 6 and 9 months corrected age and 2 and 3 years postnatal age, in preterm children with birth weight of less than 1251 g in whom high-risk prethreshold retinopathy of prematurity (ROP) developed and who participated in the Early Treatment for Retinopathy of Prematurity (ETROP) Study.
Randomized, controlled clinical trial.
Four hundred one infants in whom prethreshold ROP developed in one or both eyes and who were randomized after they were determined to have a high risk (> or =15%) of poor structural outcome without treatment using the Risk Management of Retinopathy of Prematurity (RM-ROP2) program. Refractive error was measured by cycloplegic retinoscopy. Eyes with additional retinal, glaucoma, or cataract surgery were excluded.
Eyes were randomized to receive laser photocoagulation at high-risk prethreshold ROP (early treated [ET]) or to be conventionally managed (CM), receiving treatment only if threshold ROP developed.
Astigmatism and high astigmatism at each visit. Astigmatism was classified as with-the-rule (WTR; 75 degrees -105 degrees ), against-the-rule (ATR; 0 degrees -15 degrees and 165 degrees -180 degrees ), or oblique (OBL; 16 degrees -74 degrees and 106 degrees -164 degrees ).
The prevalence of astigmatism in ET and CM eyes was similar at each test age. For both groups, there was an increase in prevalence of astigmatism from approximately 32% at 6 months to approximately 42% by 3 years, mostly occurring between 6 and 9 months. Among eyes that could be refracted, astigmatism was not influenced by zone of acute-phase ROP, presence of plus disease, or retinal residua of ROP. Eyes with astigmatism and high astigmatism most often had WTR astigmatism.
By age 3 years, nearly 43% of eyes treated at high-risk prethreshold ROP developed astigmatism of > or =1.00 D and nearly 20% had astigmatism of > or =2.00 D. Presence of astigmatism was not influenced by timing of treatment of acute-phase ROP or by characteristics of acute-phase or cicatricial ROP. These findings reinforce the need for follow-up eye examinations in infants with high-risk prethreshold ROP.
FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
研究出生体重小于1251g、发生高危阈值前早产儿视网膜病变(ROP)并参与早产儿视网膜病变早期治疗(ETROP)研究的早产儿在矫正年龄6个月和9个月以及出生后2岁和3岁时散光(≥1.00屈光度[D])和高度散光(≥2.00D)的患病率。
随机对照临床试验。
401名婴儿,其一只或两只眼睛发生阈值前ROP,在使用早产儿视网膜病变风险管理(RM-ROP2)程序确定未经治疗出现不良结构结局的高风险(≥15%)后被随机分组。通过睫状肌麻痹验光测量屈光不正。排除接受过额外视网膜、青光眼或白内障手术的眼睛。
眼睛被随机分组,在高危阈值前ROP时接受激光光凝治疗(早期治疗[ET])或进行常规管理(CM),仅在出现阈值ROP时接受治疗。
每次随访时的散光和高度散光。散光分为顺规散光(WTR;75度-105度)、逆规散光(ATR;0度-15度和165度-180度)或斜向散光(OBL;16度-74度和106度-164度)。
在每个测试年龄,ET组和CM组眼睛的散光患病率相似。对于两组,散光患病率从6个月时的约32%增加到3岁时的约42%,大多发生在6至9个月之间。在可以验光的眼睛中,散光不受急性期ROP区域、附加病变的存在或ROP视网膜残留的影响。有散光和高度散光的眼睛最常出现顺规散光。
到3岁时,在高危阈值前ROP接受治疗的眼睛中,近43%出现≥1.00D的散光,近20%出现≥2.00D的散光。散光的存在不受急性期ROP治疗时间或急性期或瘢痕期ROP特征的影响。这些发现强化了对高危阈值前ROP婴儿进行随访眼科检查的必要性。
作者对本文讨论的任何材料均无所有权或商业利益。